In previous lectures, Claude Bernard's many scientific contributions have been highlighted. Among others he suggested in 1850 that the liver stores glucose and 7 years later, in 1857, he finally isolated glycogen [2] . Before that, in 1849, Claude Bernard reported his ªPiqßre sucrØeº to the SociØtØ de Biologie, Paris [3] . In analogy to his experiments in which stimulation of the fifth cranial nerve caused saliva secretion, he assumed that stimulation of the vagus nerve would elicit glucose secretion from the liver. In unanaesthetised rabbits and dogs, the pricking of the bottom of the fourth ventricle resulted in pronounced hyperglycaemia and glucosuria within 20 min. The ªdiabetesº was transient and disappeared after a few hours. He later showed that this effect was mediated, not by the vagus, but by sympathetic nerves. His discovery of glycogen made Claude Bernard the true father of Diabetologia (2000) 
Insulin is stored in secretory granules in the beta-cell and is secreted by exocytosis. This process is precisely controlled to achieve blood glucose homeostasis. Many forms of diabetes mellitus display impaired glucose-induced insulin secretion. This has been shown to be the primary cause of the disease in the various forms of maturity-onset diabetes of the young (MODY) and has also been implicated in adult-onset Type II (non-insulin-dependent) diabetes mellitus. Glucose generates ATP and other metabolic coupling factors in the beta-cell mitochondria. By plasma membrane depolarisation ATP promotes Ca 2+ influx, which raises cytosolic Ca 2+ and triggers insulin exocytosis. Through hyperpolarisation of the mitochondrial membrane glucose also increases the Ca 2+ concentration in the mitochondrial matrix activating Ca intermediary metabolism. He considered the liver to be an organ of internal secretion, a concept nowadays reserved for endocrine function such as insulin secretion from the beta cell. Figure 1 illustrates the ultrastructure of the beta cell with its main intracellular organelles. Insulin is synthesised in the endoplasmic reticulum and transported to the Golgi complex from which the insulincontaining secretory granules are formed by budding. Only a small proportion of the stored insulin is secreted into the islet capillaries during stimulation as indicated in a striking high magnification electron micrograph showing part of a beta cell with two secretory granules (Fig. 2) . One has just fused with the plasma membrane and the granule core containing insulin in crystalline form is being washed out into the extracellular capillary space [4] . This process is referred to as exocytosis and is under intense study [5±9] . Figure 3 shows, in addition to secretory granules, beta-cell mitochondria which are the focus of this lecture. The outer and inner membranes of the mitochondria can be distinguished, as well as the inner membrane invaginations called cristae. The enzyme complexes of the respiratory (electron transport) chain are located on these cristae [10] .
Impaired insulin secretion in Type II diabetes mellitus
A brief discussion of impaired glucose-induced insulin secretion in Type II diabetes sets the stage for this review. It is well established that the first phase of insulin secretion is impaired both in patients in a prediabetic state and after manifestation of Type II diabetes [11, 12] . Such investigations were, however, generally done during i. v. glucose tolerance tests or more prolonged glucose infusions. These approaches give an inaccurate assessment of the second phase insulin release because of hyperglycaemia later in the test due to reduced initial insulin secretion [12] . When mildly Type II diabetic patients, treated by diet alone, were subjected to hyperglycaemic clamp, both phases of insulin secretion were considerably inhibited (Fig. 4) [13] . This was seen at glucose concentrations of 7.5, 10 and 15 mmol/l. Both insulin secretion and tissue sensitivity to insulin are now known to be genetically controlled.
Accordingly, beta-cell dysfunction, as well as insulin resistance, have been proposed as primary causes Field of a beta cell in a thin section for electron microscopy showing the main intracellular membrane compartments: rough endoplasmic reticulum (RER), Golgi complex, insulincontaining secretory granules (sg) and mitochondria (m). Also visible is a part of an endothelial cell delimiting a capillary lumen (En). Normoglycaemic rat. The bar represents 1 mm. Unpublished document by L. Orci of Type II diabetes [14, 15] . Hyperglycaemic clamp experiments in first-degree relatives of Type II diabetic patients showed normal glucose tolerance but there was a clear 25 % reduction in both phases of insulin secretion (Fig. 5 ). This multicentre study concluded that, in the group with a first-degree relative with Type II diabetes, impaired insulin secretion was about four to seven times more common than insulin resistance [16] . These results concur with other assessments of beta-cell function in similar cohorts and encourage further research into the mechanism of insulin secretion [14] .
Consensus model for the mechanism of insulin secretion
The beta-cell is poised to sense glucose to accomplish the moment-to-moment adaptation of insulin secretion to blood glucose fluctuations. This is made possible through particular expression profiles of carbohydrate transporters and enzymes [17, 18] in the beta- Modified and reprinted with permission from Hosker et al. [13] A B cell (Fig. 6 ). Three main molecular characteristics of glucose metabolism of the beta cell are of importance. Firstly, in beta cells like in hepatocytes, glucose equilibrates across the plasma membrane because both cell types express the high capacity, low affinity glucose transporter GLUT 2 [17] . In human beta cells, GLUT 2 is only moderately expressed and GLUT 1 dominates [19] . Secondly, glucose phosphorylation to glucose-6-phosphate is catalysed by high K M hexokinase IV called glucokinase (GK) which constitutes the flux determining step for glycolysis [17±20]. This enzyme was early proposed to be the ªglucose sensorº [18] and it is now known that mutations in glucokinase underlie the impaired insulin secretion in MODY2 patients [21] . Thirdly, pyruvate generated by glycolysis is channelled to the mitochondria. Indeed, more than 90 % of glucose carbons entering the beta cell are converted to CO 2 in the mitochondria [22] . In addition, the beta cell has extremely low concentrations of lactate dehydrogenase (LDH), the enzyme catalysing the conversion of pyruvate to lactate [22±24] . Furthermore, monocarboxylate transporter activity in the plasma membrane is low, which explains why pyruvate and lactate are not insulin secretagogues in native beta cells [23, 24] . Pyruvate, which enters the mitochondria, provides substrate to the Krebs or tricarboxylic acid (TCA) cycle. This generates ATP and other mitochondrial factors, which promote insulin secretion [17, 18, 22, 25, 26] . Substrate shuttles across the inner mitochondrial membrane also participate in the generation of mitochondrial signals by glucose [17, 27] . How, then, is glucose metabolism coupled to insulin secretion? The universal intracellular second messenger Ca 2+ [28] is the crucial trigger for the exocytosis of insulin [5] . The concentration of ionised Ca 2+ in the cytosol is raised by glucose in the following way. The increased TCA cycle activity leads to the production of reducing equivalents NADH and the reduced form of flavin adenine dinucleotide (FADH 2 ) in the mitochondrial matrix [29±31]. Thereby electrons are transferred to the electron transport chain which also receives electrons from the glycerol phosphate shuttle [17, 27] . This has two consequences. Firstly, ATP is generated and transferred to the cytoplasm [25] . Secondly, the membrane potential across the inner mitochondrial membrane (Dy m ) is hyperpolarised, becoming more negative inside [26, 30, 32] . The cytosolic ATP, or rather the ATP:ADP ratio increases [18, 33] , causing closure of ATP-sensitive K + (K ATP ) channels. This was first shown in 1984 in excised beta-cell plasma membrane patches [34] and in glucose-stimulated intact cells [35] . Closure of K ATP channels depolarises the plasma membrane potential and causes typical electrical activity first observed 30 years ago [36] . The depolarisation evokes the opening of voltage-sensi- . Metabolism-secretion coupling in the beta cell. Glucose (Glc) is phosphorylated by glucokinase (GK). Glucose 6-phosphate (Glc-6P) is converted to pyruvate (Pyr) through glycolysis and is transported into the mitochondria to provide substrates to the tricarboxylic acid (TCA) cycle. The generated electrons are transferred to the respiratory chain (e-transport) which can also be directly stimulated by redox shuttles. Hyperpolarisation of the mitochondrial membrane potential (Dy m ) increases in [Ca 2+ ] m . The ATP-sensitive K + channels are closed through metabolism. They are directly controlled by sulphonylureas and diazoxide. Their closure depolarises the plasma membrane potential (Dy). The voltage-gated Ca 2+ entry raises cytosolic Ca 2+ and triggers insulin exocytosis. Leu = Leucine tive Ca 2+ channels, which are mainly of L-type [37, 38] and Ca 2+ enters the cell along its electrochemical gradient. In the presence of ATP, Ca 2+ stimulates exocytosis of insulin granules [5, 39] . The Ca 2+ is, however, not only required for exocytosis but also seems to act as a messenger molecule inside the mitochondria, as first suggested for heart and liver cells [40] . This, as discussed below, occurs by mitochondrial membrane potential-driven Ca 2+ entry and activation of the TCA cycle. It should be noted that, in contrast to glucose, the amino acid leucine, a physiological insulin secretagogue, is not transformed in the cytoplasm but directly enters the mitochondria. The subsequent generation of acetyl CoA stimulates the TCA cycle [41] . Consequently, the same down-stream effects as seen with glucose are set in motion. Leucine can thus be used to probe for defects in the metabolic pathway of glucose that precede the TCA cycle. Unfortunately, few clinical studies in diabetic patients have been done with leucine [42] . Instead, arginine is frequently used [12] . Arginine is only weakly metabolised by beta cells. The cationic amino acid depolarises the membrane potential following its accumulation in the beta cell, resulting in an increase in cytosolic Ca 2+ [43] . Finally, sulphonylureas bind to the sulphonylurea receptor (SUR), a component of the ATP-sensitive K + channels, thereby promoting their closure and membrane depolarisation. The sulphonylurea analogue diazoxide has the opposite effect, causing channel opening and hyperpolarisation (Fig. 6) [44] .
From the model to some illustrations of the model. Primary islet preparations have been extremely valuable models for biochemical studies. The laboratories of B. Hellman [45] . W. Malaisse [46] and F. Matschinsky [18] , as well as many others have advanced our knowledge of stimulus-secretion coupling in the beta cell.
Over the last two decades permanent beta cell lines have proved to be essential for such studies as they can be genetically manipulated with great ease. We use a highly differentiated rat insulinoma cell line, INS-1, which was established in our laboratory [47] . These cells respond to an increase in the glucose concentration from 2.8 to 10 mmol/l with a biphasic insulin secretion (Fig. 7) [47, 48] . For assessment of signal transduction, the cells were stably transfected with proteins permitting the monitoring of intracellular messengers. Using luciferase-expressing cells, P. Maechler showed that glucose increases cytoplasmic ATP in living cells [25] . This precedes the rise in cytosolic Ca
2+ measured with the Ca 2+ -sensitive photoprotein aequorin. The biphasic increase in cytosolic Ca 2+ is associated with a biphasic increase in the Ca 2+ concentration inside the mitochondria [48, 49] . Leucine, like glucose, raises the cytosolic and mitochondrial Ca 2+ concentrations [49] . The cytosolic Ca 2+ rise, together with the coupling factors of mitochondrial origin [32] , evoke insulin secretion (Fig. 7) .
Ca
2+ activation of mitochondrial metabolism
Is the rise in mitochondrial Ca 2+ involved in signal generation? It was first shown by Jean-Claude Henquin [50, 51] and Toru Aizawa [52] and their collaborators that glucose could stimulate insulin secretion in a K ATP -channel independent manner. In a now widely used experimental paradigm, diazoxide was added to inhibit the closure of K ATP -channels by glucose (Fig. 6 ). This agent eliminates glucose-induced electrical activity, the rise in cytosolic Ca 2+ and insulin release. Instead, the plasma membrane potential (Dy) is depolarised by K + causing an increase in cytosolic Ca 2+ to permissive concentrations. Despite the presence of diazoxide, the addition of stimulatory glucose concentrations promotes insulin secretion, resembling the slowly increasing second phase of secretion (Fig. 8) [50, 51] .
What is the mechanism underlying the K ATP -channel independent stimulation of insulin release? We hypothesised that a permissive increased cytosolic Ca 2+ is required for activation of Ca 2+ -sensitive enzymes in the mitochondrial matrix. These enzymes are pyruvate dehydrogenase (PDH) which catalyses the conversion of pyruvate to acetyl CoA, the two TCA cycle enzymes, NAD-isocitrate dehydrogenase which generates a-ketoglutarate and a-ketoglutarate dehydrogenase producing succinyl CoA [40, 49, 53±56] . To show the role of Ca 2+ in mitochondrial activation, we used the TCA cycle intermediate succinate which enters the cycle at the succinate dehydrogenase step (Fig. 9) . The latter enzyme links the TCA cycle and the respiratory chain, of which it constitutes complex II [10] . Succinate, in contrast to its methyl derivatives, does not enter intact beta cells and therefore permeabilised cells were used. Native beta cells or INS-1 cells were permeabilised with Staphylococcus aureus a-toxin [32] . The a-toxin makes small holes in the plasma membrane but leaves the organellar membranes intact. This allows the clamping of the cytosolic concentrations of ions and nucleotides such as Ca 2+ and ATP , mitochondrial Ca 2+ and the generation of other coupling factors all contribute to biphasic glucose-stimulated insulin secretion whereas the pores do not allow passage of proteins (Fig. 10) . At the permissive Ca 2+ concentration of 500 nmol/l succinate metabolism was increased fourfold compared with 100 nmol/l Ca 2+ [56] , the resting intracellular Ca 2+ concentration of the beta cell [5] . This was measured as 14 CO 2 production from [ 14 C]-labelled succinate which reflects the activity of the two Ca 2+ -sensitive TCA cycle enzymes (Fig. 9) . Similar results have been published previously [55] for the activation of pyruvate dehydrogenase by Ca 2+ in permeabolised HIT-T15 cells, a hamster beta-cell line.
Mitochondrial activation directly stimulates insulin exocytosis
Is the increased metabolism of succinate accompanied by stimulation of insulin secretion? In the permeabilised INS-1 cells, succinate hyperpolarises the Dy m which on the other hand, is completely depolarised by the uncoupler carbonyl cyanide p-trifluoromethyl oxyphenyl-hydrazone (FCCP) (Fig. 11) . The succinate-induced hyperpolarisation explains the rise in mitochondrial Ca 2+ [32, 49, 56] . Succinate caused a pronounced biphasic stimulation of insulin secretion (Fig. 11) . This stimulation was shown to depend on both the rise in mitochondrial Ca 2+ and provision of carbons to the TCA cycle [32] . We can conclude from these and other experiments that increased succinate metabolism in the mitochondria leads to stimulation of the electron transport chain resulting in the hyperpolarisation of the Dy m . This drives Ca 2+ uptake by the mitochondria. The mitochondrial Ca 2+ increase acts in a feed-forward manner to stimulate the TCA cycle (Fig. 9 ). This in turn generates a mitochondrial factor which activates the exocytotic release of insulin. The same sequence of events is seen in intact cells stimulated with glucose, i. e. hyperpolarisation of Dy m and increased mitochondrial Ca 2+ and TCA cycle-dependent generation of a coupling factor distinct from ATP [32, 48, 49, 56] . The mitochondrial factor was subsequently identified as glutamate [57] .
Role of mitochondrial DNA in insulin secretion
It is thus clear that the respiratory chain is crucial for signal generation not only from succinate but also from glucose. The five enzyme complexes (CI to CV) of the chain are localised on the cristae of the inner mitochondrial membrane and the electron flux . The latter two enzymes generate electrons and CO 2 . Note that succinate dehydrogenase constitutes complex II of the respiratory chain establishes a proton gradient across the inner membrane by extrusion of protons at complexes I, III and IV (Fig. 12 ). This proton gradient provides the energy for ATP synthesis from ADP and inorganic phosphate at complex V, the ATP synthase [10, 58] . Collapse of the proton gradient results in dissipation of the membrane potential (as elicited by FCCP) and blocks ATP synthesis [25] . The respiratory chain complexes are comprised of about one hundred polypeptide subunits of which 13 are encoded by the mitochondrial DNA, the remainder by the nuclear DNA. Nuclear DNA regulates the replication, transcription and translation of the mitochondrial DNA. This occurs through the import of proteins from the cytosol. Together the nuclear and the mitochondrial DNA accomplish the expression of the respiratory chain enzymes and normal oxidative phosphorylation [58±60] . Defects in oxidative metabolism lead to various disease phenotypes involving mainly organs of high energy need such as muscle, neurons and endocrine cells [58±61] .
The first mitochondrial disease was described by Rolf Luft and associates in 1959 who reported a hypermetabolic syndrome in a patient with normal thyroid function [62, 63] . In 1992, linkage was described between mitochondrial DNA mutations and diabetes for both a deletion [64] and a point mutation [65] . The mitochondrial genome is a compact doublestranded DNA containing almost exclusively coding regions. In addition to the 13 polypeptides of the respiratory chain enzyme complexes, the mitochondrial DNA (mtDNA) encodes 22 transfer RNAs and two ribosomal RNAs [58±61]. A mutational hot spot seems to be the tRNA Leu(UUR) [61, 66] . Mitochondrial diabetes accounts for approximately 1 to 2 % of all cases of diabetes [58, 66] . The disease is maternally inherited due to the transmission mode of mtDNA. The patients show progressive impairment of insulin secretion and the type 2 phenotype may eventually deteriorate to overt insulin dependence. There is a frequent association with nerve deafness. The mitochondrial DNA mutations include deletions, substitutions and point mutations, e. g. in position bp3243 of tRNA Leu(UUR) . Patients with the mutation in position bp3243 in the tRNA Leu(UUR) gene have impaired insulin secretion during an oral glucose tolerance test. The impairment was found to be most pronounced in diabetic patients also suffering from deafness [66] . To gain further insight into the function of the mitochondria that carry DNA mutations, clonal cell lines (cybrids) have been established which harbour these mitochondria [67] . Skin fi- broblasts, like all cells from patients with the 3243 point mutation in the tRNA Leu(UUR) , are heteroplasmic, that is, mutated and non-mutated mitochondrial DNA coexist within the same cell. In a patient with this mutation, 63 % heteroplasmy of mtDNA was reported in beta cells, a value much higher than in the other tissues examined [68] . To enrich for mutated DNA, the skin fibroblasts were enucleated to yield cytoplasts containing the mitochondria. These cytoplasts were then fused with recipient cells, an osteosarcoma cell line, which had been depleted of mitochondrial DNA (r 0 cells) by treatment with ethidium bromide [67] . This agent binds to DNA and because of the low repair capacity of mitochondrial DNA there is elimination of mitochondrial but not of nuclear DNA [69] . After fusion of patient cytoplasts with the recipient mitochondria-free r 0 cells, cybrids were established. These were selected for clones with the highest degree of heteroplasmy, approaching 100 % mutated mtDNA and were compared with cybrids containing 100 % non-mutated (wild-type) mtDNA. The cell lines replenished with mutated mtDNA exhibit considerably reduced oxidative phosphorylation as reflected by reduced O 2 consumption [67] . The mitochondria harbouring mutated mtDNA also present A B altered morphology. When stained with the mitochondria dye Mito Tracker they are small and rounded, resembling those of the r 0 cells. This contrasts with the normal mitochondria which have rod and filament-like shapes [67] .
Beta-cell model of mitochondrial diabetes
The importance of intact mtDNA for normal insulin secretion can also be studied directly in insulin-secreting cells using a similar approach. Our group established mitochondrial DNA-deficient r 0 INS-1 cells. Again, the mitochondria of the r 0 cells were small and round, contrasting with the typical rod shape of the control cells. These r 0 cells were indeed deficient in oxidative phosphorylation as shown by the absence of detectable cytochrome c oxidase activity. Furthermore, glucose failed to hyperpolarise Dy m and did not increase ATP concentrations in INS-1 r 0 cells [26] . Thus glycolysis alone is not sufficient to generate appropriate increases in ATP. Do INS-1 r 0 cells secrete insulin? Glucose-stimulated insulin secretion was completely abolished in the r 0 cells, whereas depolarisation with potassium, which raises cytosolic Ca 2+ independent of cellular metabolism [48, 51] , still evoked insulin secretion (Fig. 13) . Thus the chemical elimination of mitochondrial DNA leads to complete inhibition of glucose-stimulated insulin secretion [26] . Some experiments have, however, shown that formation of cybrids between enucleated donor cells containing normal mitochondria and r 0 cells of the mouse beta-cell line MIN6 permitted restoration of glucose-induced insulin secretion [70] . These experiments thus unequivocally show the pivotal role of the mitochondria in glucose-stimulated insulin secretion.
Maturity-onset diabetes of the young
Maturity-onset diabetes of the young (MODY) is a monogenic, autosomal dominant, early onset form of Type II diabetes which was first described by Stefan Fajans in 1975 [71] . It could account for 2 to 5 % of Type II diabetic patients [72] . In 1992 MODY2 was linked to mutations in glucokinase [73] . In 1996, the genes for MODY1 and MODY3 were identified, respectively as hepatocyte nuclear factor 4a (HNF-4a) [74] and HNF-1a [75] . The MODY4 subform is also a transcription factor, namely IPF-1/IDX-1/PDX-1/ STF-1/IUF-1 (a dear child bears many names!) [76] . Mutations in IPF-1 have very recently been suggested to confer susceptibility to late-onset Type II diabetes [77, 78] . The rare MODY5 subform has been linked to HNF-1b [79] . The genes for additional MODY sub-types are now being described [80] . The MODY2 subform is less severe [21] than the others [74, 75] , many of which can eventually require insulin therapy [81, 82] . Except in MODY2, microvascular complications are generally present [81, 82] . In all cases, the pathophysiology involves beta-cell dysfunction. Patients with MODY3 barely respond to glucose with stimulation of insulin secretion, whereas Tetracycline doxycycline produces dominant-negative HNF1a (s) which forms non-functional dimers with the endogenous, wild-type HNF-1a ( ). Thereby the transcription of HNF-1a target genes is suppressed the marker-positive subjects without diabetes respond normally at intermediate glucose concentrations. Above 8 mmol/l, they also, however, have considerable inhibition of insulin secretion during graded i. v. glucose infusions [83] . The MODY3/HNF-1a gene comprises ten exons. Mutations have been described in the promoter region and in all exons [75, 81, 82] . The gene encodes a dimerisation domain at the N-terminus of the protein, a DNA-binding domain in the middle of the molecule and a C-terminal transactivation domain [81, 84] . Mutations can cause loss of function either by haploinsufficiency, that is, reduced gene dosage, or through a dominant-negative mechanism.
Beta-cell model of MODY3
Our group investigated the dominant-negative action of HNF-1a mutations to examine the role of the transcription factor in gene expression and metabolism-secretion coupling in the beta cell [85] . Controlled overexpression of HNF-1a mutations was achieved (Fig. 14) . In a two-step procedure, the dominant-negative HNF-1a was placed under the control of the reverse tetracycline transactivator. When such INS-1 cells are exposed to doxycycline, a tetracycline analogue, the increased binding of the reverse tetracycline transactivator promotes transcription of the dominant-negative HNF-1a. As this expression exceeds that of the endogenous wild-type HNF-1a, non-functional dimers are formed. Hepatic nuclear factor 1a can only activate transcription after dimerisation. Because the dominant-negative HNF-1a mutants are devoid of DNA-binding capacity, the complexes can no longer attach to the HNF-1a binding sites in the specific promoter regions of the target genes [84] . The transcription of insulin, of the glucose transporter GLUT 2 and of liver-type pyruvate kinase was suppressed in INS-1 cells after treatment with doxycycline [85] .The induction of dominantnegative HNF-1a also affects metabolism-secretion coupling.
Two days of induction of dominant-negative HNF1a considerably reduced both glucose and leucine oxidation (Fig. 15) . This was measured as the production of 14 CO 2 from 14 C-labelled nutrients. Similarly, ATP production during stimulation with either glucose or leucine was completely abolished. This was associated with suppressed glucose-stimulated insulin secretion. The effect evoked by leucine was also strongly inhibited. The cells still synthesised and stored insulin as potassium depolarisation-mediated secretion was much less affected (Fig. 15) [85] .
We can surmise that HNF-1a not only controls the expression of insulin and the glucose transporter GLUT 2 but also controls generation of metabolic coupling factors in the mitochondria (Fig. 16) . After suppression of HNF-1a function TCA cycle activity is decreased, as reflected by reduced CO 2 production from glucose and leucine. Consequently, the ATP production evoked by both glucose and leucine was abolished. This results in impaired membrane depolarisation and cytosolic Ca 2+ rises elicited by the two nutrient secretagogues [85] . It has been observed that both glucose-stimulated insulin secretion and cytosolic Ca 2+ rises are abrogated in islets from HNF-1a knock-out mice [86] . These mice are diabetic but in contrast to MODY3 patients heterozygous mice are normoglycaemic. Although MODY is a monogenic disease, it can teach us many lessons for the better understanding of the more common forms of Type II diabetes. In particular, the role of transcription factors in the aetiology of the disease must be further investigated [77, 78] . induced. Reprinted with permission from Wang et al. [85] 
Conclusion
One of Claude Bernard's principles for medical science was the importance of the close relation between the clinic and the research laboratory. This concept is of high actuality in diabetes research where the description of specific clinical phenotypes has led to the discovery of the MODY diabetes genes. The impact of mutations in these genes on beta-cell function will most certainly help to clarify the role of the mitochondria in the common polygenic form of Type II diabetes. This should be achieved through identification of new target genes for HNF-1a and the other transcription factors which have been linked to the monogenic MODY syndromes. Further clinical studies with leucine and other insulin secretagogues of known mitochondrial action should help explain the proposed dysfunction of mitochondrial signal generation in the beta cell of the Type II diabetic patient. The definition of new metabolic coupling factors of mitochondrial origin [57] will also further our understanding of clinical conditions with impaired insulin secretion or with hyperinsulinism [87] . The support to my research by the Swiss National Science Foundation is gratefully acknowledged. Fig. 16 . Metabolism secretion coupling of nutrient-induced insulin release is controlled at multiple sites by the transcription factor HNF-1a. Dominant-negative HNF-1a suppresses GLUT 2 at the plasma membrane and lowers mitochondrial metabolism of both glucose and leucine. This reduces the generation of ATP and other mitochondrial factors required for the increase in cytosolic Ca 2+ and the exocytosis of insulin
